Cargando…

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Spironolactone, an antagonist of aldosterone, initially used as a potassium-sparing diuretic, was subsequently shown to be a very effective adjunctive agent in the treatment of patients with heart failure with reduced ejection fraction, by halting the disease progression, with significant beneficial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manolis, Antonis A, Manolis, Theodora A, Melita, Helen, Manolis, Antonis S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941679/ https://www.ncbi.nlm.nih.gov/pubmed/31920323 http://dx.doi.org/10.2147/VHRM.S210150

Ejemplares similares

Neurohumoral Activation in Heart Failure
por: Manolis, Antonis A., et al.
Publicado: (2023)

COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management
por: Manolis, Antonis S., et al.
Publicado: (2020)

COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship
por: Manolis, Antonis S., et al.
Publicado: (2021)

COVID-19 infection and cardiac arrhythmias
por: Manolis, Antonis S., et al.
Publicado: (2020)

Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue
por: Manolis, Antonis S., et al.
Publicado: (2023)

Pulmonary vein reconnection following cryo-ablation: Mind the “Gap” in the carinae and the left atrial appendage ridge
por: Manolis, Antonis S., et al.
Publicado: (2019)

Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe  Derived from Single Operator Experience and Review of the Literature
por: Manolis, Antonis S.
Publicado: (2017)

Use, tolerability and compliance of spironolactone in the treatment of heart failure
por: Lachaine, Jean, et al.
Publicado: (2011)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Simplified swift and safe vascular closure device deployment without a local arteriogram: Single center experience in 2074 consecutive patients()
por: Manolis, Antonis S., et al.
Publicado: (2016)

Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients
por: Manolis, Antonis S., et al.
Publicado: (2018)

Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment
por: Choy, Manting, et al.
Publicado: (2022)

Putting the Spotlight Back on Plant Suspension Cultures
por: Santos, Rita B., et al.
Publicado: (2016)

Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection
por: Kosmas, Nikolaos, et al.
Publicado: (2020)

Author`s Reply
por: Manolis, Antonis S., et al.
Publicado: (2018)

Author`s Reply
por: Manolis, Antonis S., et al.
Publicado: (2018)

Cardiac implantable electronic device lead extraction using the lead-locking device system: keeping it simple, safe, and inexpensive with mechanical tools and local anesthesia
por: Manolis, Antonis S., et al.
Publicado: (2017)

Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
por: Bounthavong, Mark, et al.
Publicado: (2018)

Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China—The China PEACE Retrospective Heart Failure Study
por: Yu, Yuan, et al.
Publicado: (2022)

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives
por: Costa, Ricardo, et al.
Publicado: (2016)

Discussing the Concept of Crisis in Cultural-historical Activity Research: a Dialectical Perspective
por: Dafermos, Manolis
Publicado: (2022)

The Utilization of Spironolactone in Heart Failure Patients at a Tertiary Hospital in Saudi Arabia
por: Alotaibi, Abdulmalik S, et al.
Publicado: (2020)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
por: Anagnostou, Theodora, et al.
Publicado: (2017)

Efficacy and safety of spironolactone for the treatment of patients with acute heart failure: A protocol for systematic review
por: Feng, Yan-lin, et al.
Publicado: (2020)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
por: Coffman, Melissa, et al.
Publicado: (2021)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study
por: Zhou, Hui‐min, et al.
Publicado: (2022)

“Heart failure in COVID-19 patients: Critical care experience”: A letter to the editor
por: Tsigkou, Vasiliki, et al.
Publicado: (2022)

Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients
por: CHEN, ZHI-HAO, et al.
Publicado: (2016)

Short-term effects of sugar-free apricot jam, cocoa powder and dried cranberry cereal bar on glycaemic responses in healthy adults: a randomised clinical trial
por: Papakonstantinou, Emilia, et al.
Publicado: (2022)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction
por: Belkin, Mark N., et al.
Publicado: (2021)

Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction
por: Hyun, Junho, et al.
Publicado: (2021)

Focusing the spotlight on GSK-3 in aging
por: Zhou, Jibin, et al.
Publicado: (2013)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives
por: Bupathi, Manojkumar, et al.
Publicado: (2016)

PepMANDIS: A Peptide Selection Tool for Designing Function-Based Targeted Proteomic Assays in Complex Microbial Systems
por: Medvecky, Matej, et al.
Publicado: (2021)

Effects of spironolactone in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials
por: Li, Shuai, et al.
Publicado: (2018)

Focusing the Spotlight on Lack of Access to Health Information
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_19knlmffi7uv6ipl44r75m4euf